Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger

  • 📰 CNBC
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 72%

日本 ニュース ニュース

Hong Kong biotech start-up is set to list on the Nasdaq in a SPAC merger
日本 最新ニュース,日本 見出し

Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, a source told CNBC.

Prenetics is a diagnostic and genetic testing company with significant operations in Hong Kong and the U.K.

Signage for Prenetics, a Hong Kong-based biotechnology company, at the company's laboratory in Hong Kong, China, on Jan. 26, 2018.Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition, a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng, according to a source close to the deal.

The transaction is expected to close by the end of this year. UBS, Citi, Credit Suisse and CICC are financial advisors on the potential de-SPAC transaction.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

CNBC /  🏆 12. in JP
 

What a forgettable name!

日本 最新ニュース, 日本 見出し